about
Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanomaPathophysiology of placentation abnormalities in pregnancy-induced hypertensionTargeting migration inducting gene-7 inhibits carcinoma cell invasion, early primary tumor growth, and stimulates monocyte oncolytic activityOverexpression of carcinoma and embryonic cytotrophoblast cell-specific Mig-7 induces invasion and vessel-like structure formationEvading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumorsBrain tumor-targeted drug delivery strategiesTumor cell vasculogenic mimicry: from controversy to therapeutic promiseThe ZNF304-integrin axis protects against anoikis in cancerPutting tumours in contextUpregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathwayVascular channels formed by subpopulations of PECAM1+ melanoma cells.Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.Vasculogenic mimicry and pseudo-comedo formation in breast cancer.Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks.Tumour vascularization: sprouting angiogenesis and beyondEpithelial-mesenchymal transition regulated by EphA2 contributes to vasculogenic mimicry formation of head and neck squamous cell carcinoma.The proliferation, apoptosis, invasion of endothelial-like epithelial ovarian cancer cells induced by hypoxiaEpidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagenMICU1 drives glycolysis and chemoresistance in ovarian cancer.Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikisVascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in GlioblastomaEndothelium originated from colorectal cancer stem cells constitute cancer blood vesselsFocal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma.Identification of a metalloprotease-chemokine signaling system in the ovarian cancer microenvironment: implications for antiangiogenic therapy.Converging evidence for efficacy from parallel EphB4-targeted approaches in ovarian carcinoma.The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.Early contribution of pericytes to angiogenic sprouting and tube formation.Vasculogenic mimicry.Angiogenesis in ovarian cancer: molecular pathology and therapeutic strategies.Multivalent epigenetic marks confer microenvironment-responsive epigenetic plasticity to ovarian cancer cells.A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro.Cellular actions and signaling by endostatin.Biological significance of focal adhesion kinase in ovarian cancer: role in migration and invasionThe merits of vascular targeting for gynecologic malignancies.Stress hormone-mediated invasion of ovarian cancer cells.Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.Focal adhesion kinase silencing augments docetaxel-mediated apoptosis in ovarian cancer cellsIRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer.XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.
P2860
Q24300402-31661A54-0463-4415-9DC6-22FA9220C3A1Q24649934-5853DE96-D8ED-4CAA-8B0F-EB663968B5E7Q24650655-B4AE00CA-FDF8-4843-9933-F81057ED03C0Q24681648-1C73C282-014D-4809-8D98-E65DF9404AF8Q26773795-4F641EB6-BC38-4F87-88F1-6E28FA9AACDBQ26829741-FBCBA417-9B25-4BC7-918F-9837F143E99DQ26829921-FD204FAF-5358-4B46-AC9B-6BA5F1BEB75FQ28115264-C22DA715-5448-4388-93EC-18A38335C1B8Q28207789-3991D0BB-236C-4006-8E10-91849DD85592Q28539122-C6D1CCA2-74FD-4D13-8AD6-111A6B905D8CQ30413784-C3B59B20-EF4E-4519-86F9-89BBF01ED801Q30483685-894B1308-6A7A-4E29-88EA-364CCB7C309FQ30836417-90E0F869-580F-4402-8774-BADB065D07C1Q33286127-62625957-4160-4D8D-A2AB-098A6120ACF8Q33556162-AF4C7F20-8F23-4A62-99BD-6DE16A35BD94Q33594147-E1E12C86-34C9-4EDA-A2B0-798D19F04A82Q33690020-3177DF53-8155-4890-8113-6C46B5FA8E89Q33744931-2D1B3568-7929-4F99-873E-D327997CC823Q33815720-DDDE929B-F6BF-41E2-971F-181BD400771FQ33815723-42BC227E-4A13-44BF-A7CB-50DB111B2ABFQ33868524-EF0D2D51-4847-41DC-9C86-4D9A49557128Q33873312-129549D1-2DD6-432E-8843-AF9FCF6CFA90Q33911213-2A79BF0E-A2D2-4879-B79A-C987599500C9Q33921567-27EB4539-7501-4654-9400-FAE8D21FE7F3Q34048965-88506AD9-C55F-4F94-8666-BC424FE43A4CQ34104147-1D47AE8A-C5C6-4F08-8860-F4411E7622F7Q34365135-ABE29F82-637C-478B-A227-F895C3AF9728Q34367285-17FC1D3B-9B03-4E53-A94F-B3C66065587DQ34371070-F345A5B4-1DFC-45AA-9200-E8299D86C01CQ34514125-99FF17A3-17C8-47C9-AAB1-D0E8EF443A86Q34643691-5B3414A8-5868-4CB7-B54B-032F62D27A68Q34995053-50EA74A9-FB8E-4930-9FFE-1DED2A4A2F1FQ35008096-E78F2948-599B-4F2F-B4CF-EC5E0FC4BD4BQ35103303-737E749F-0B63-4ECF-8430-0BDCD755B840Q35116734-3DA67CE4-03C9-4A82-B5EA-3B87C6B2267EQ35120288-8BBEF02C-3348-434C-BCDE-44C49A424DFAQ35130437-8428D33B-3E75-4509-8984-B83FA53E7DAFQ35131712-2BDB8EB8-E5FC-4719-BDA3-2D2E60E2A1FDQ35529018-D8C243C7-5580-43EB-9FDF-8F1A1F7BE3C4Q35602930-888A76C4-AE1D-48A0-BABD-BD8B1B99FC90
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Molecular determinants of ovarian cancer plasticity.
@ast
Molecular determinants of ovarian cancer plasticity.
@en
type
label
Molecular determinants of ovarian cancer plasticity.
@ast
Molecular determinants of ovarian cancer plasticity.
@en
prefLabel
Molecular determinants of ovarian cancer plasticity.
@ast
Molecular determinants of ovarian cancer plasticity.
@en
P2093
P2860
P1476
Molecular determinants of ovarian cancer plasticity.
@en
P2093
E A Seftor
L M Gardner
M J Hendrix
M S Fletcher
P M Heidger
R E Buller
R E Seftor
P2860
P304
P356
10.1016/S0002-9440(10)64079-5
P407
P577
2001-04-01T00:00:00Z